Pancreatic Extracts for the Treatment of Diabetes (1889-1914): Acomatol.
Journal
American journal of therapeutics
ISSN: 1536-3686
Titre abrégé: Am J Ther
Pays: United States
ID NLM: 9441347
Informations de publication
Date de publication:
Historique:
pubmed:
11
10
2019
medline:
9
6
2020
entrez:
11
10
2019
Statut:
ppublish
Résumé
Historical review on the early development of organotherapy for diabetes [pancreatic extracts (PE)] and its relationship with the social and political circumstances. The diagnosis of diabetes relied only in the presence of glycosuria and cardinal symptoms. Blood glucose determinations were not regularly available, requiring large volumes for sampling. Micromethods for glycemia were developed just in the last years of the investigated period. Hypoglycemia remains undiscovered. Isolation and purification of PE were difficult tasks due to the unknown chemical structure of the antidiabetic hormone. (1) Berliner Medizinhistoriches Museum der Charité (Humboldt University). (2) GeDenKort Charité-Wissenschaft in Verantwortung. (3) Geheim Staatsarchiv Preuβischer Kulturbesitz. (4) Archival Collections, University of Toronto: Thomas Fisher Rare Book Library. Academy of Medicine Collection, F. G. Banting Papers, C. H. Best Papers, J. J. R. Macleod Papers. (5) National Library of Medicine: Pubmed search for the topic of history of insulin. History of Medicine-on syllabus archive. (6) Selected books: The Discovery of Insulin (M. Bliss); Diabetes, Its Medical and Cultural History (D. von Engelhardt); Brown-Séquard (M. J. Aminoff); Diabetes: The Biography (R. Tattersall); The Endocrine Organs (E. Schäfer); The Internal Secretions (E. Gley); Health, race and German politics between national unification and Nazism, 1870-1945 (P. Weindling). Demonstration that diabetes is a pancreatic disease. The outstanding progress of medical physiology led to the birth of endocrinology and the key concepts of homeostasis. Experimental scientists designed new procedures for complete pancreatectomy and elaboration of PE containing the antidiabetic principle. Organotherapy achieved complete success in the treatment of myxedema and partial success in the treatment of experimental and clinical diabetes. The organotherapy of diabetes was an obliged step to facilitate the identification of the antidiabetic hormone. Organotherapy of diabetes was a paradigm for the integration of basic and applied knowledge about hormone action and development of endocrine pharmacology.
Sections du résumé
BACKGROUND
BACKGROUND
Historical review on the early development of organotherapy for diabetes [pancreatic extracts (PE)] and its relationship with the social and political circumstances.
AREAS OF UNCERTAINTY
UNASSIGNED
The diagnosis of diabetes relied only in the presence of glycosuria and cardinal symptoms. Blood glucose determinations were not regularly available, requiring large volumes for sampling. Micromethods for glycemia were developed just in the last years of the investigated period. Hypoglycemia remains undiscovered. Isolation and purification of PE were difficult tasks due to the unknown chemical structure of the antidiabetic hormone.
DATA SOURCES
METHODS
(1) Berliner Medizinhistoriches Museum der Charité (Humboldt University). (2) GeDenKort Charité-Wissenschaft in Verantwortung. (3) Geheim Staatsarchiv Preuβischer Kulturbesitz. (4) Archival Collections, University of Toronto: Thomas Fisher Rare Book Library. Academy of Medicine Collection, F. G. Banting Papers, C. H. Best Papers, J. J. R. Macleod Papers. (5) National Library of Medicine: Pubmed search for the topic of history of insulin. History of Medicine-on syllabus archive. (6) Selected books: The Discovery of Insulin (M. Bliss); Diabetes, Its Medical and Cultural History (D. von Engelhardt); Brown-Séquard (M. J. Aminoff); Diabetes: The Biography (R. Tattersall); The Endocrine Organs (E. Schäfer); The Internal Secretions (E. Gley); Health, race and German politics between national unification and Nazism, 1870-1945 (P. Weindling).
THERAPEUTIC ADVANCES
UNASSIGNED
Demonstration that diabetes is a pancreatic disease. The outstanding progress of medical physiology led to the birth of endocrinology and the key concepts of homeostasis. Experimental scientists designed new procedures for complete pancreatectomy and elaboration of PE containing the antidiabetic principle. Organotherapy achieved complete success in the treatment of myxedema and partial success in the treatment of experimental and clinical diabetes.
CONCLUSIONS
CONCLUSIONS
The organotherapy of diabetes was an obliged step to facilitate the identification of the antidiabetic hormone. Organotherapy of diabetes was a paradigm for the integration of basic and applied knowledge about hormone action and development of endocrine pharmacology.
Identifiants
pubmed: 31599767
doi: 10.1097/MJT.0000000000001070
pii: 00045391-202001000-00001
doi:
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Pancreatic Extracts
0
Types de publication
Historical Article
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1-e12Références
Bernard C. Introduction à l’ étude de la médecine expérimentalle. Paris, France: B. Baillière; 1865.
Bernard C. Leçons sur Le Diabète et la glycogenèse animal (Troisième Leçon). Paris, France: B. Baillière; 1877.
Bernard C. Leçons sur la Physiologie et la Pathologie du Système Nerveux. Cours de médecine du College de France. Paris, France: B. Baillière; 1858.
Bernard C. Mémoire sur le pancreas et sur le role du suc pancréatique dans les phénoménes digestifs. Paris, France: B. Baillière; 1856.
Langerhans P. Beiträge zur mikroskopischen. Anatomie der Bauchspeicheldrüse. Berlin, France: Diss. Med.; 1869.
Laguesse GE. Sur la formation des ilots de Langerhans dans le pancréas. C R Soc Biol. 1893;45:819–820.
Lancereaux É. Notes et réflexions sur deux cas de diabète sucré avec alteration du pancréas. Bull Acad Méd. 1877;VI:1215.
von Mering J, Minkowski O. Diabetes mellitus nach Pankreasextirpation. Arch Exp Pathol Pharmakol. 1889;26:371–387.
Luft R. Oskar Minkowski: discovery of the pancreatic origin of diabetes. Diabetologia. 1989;32:399–401.
Opie EL. The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of Islands of Langerhans. J Exp Med. 1900;5:527–540.
Opie EL. Disease of the Pancreas—Its Cause and Nature. Philadelpia, PA: J.B. Lippincott; 1903.
Schadewaldt H. The history of diabetes mellitus. In: von Engelhardt D, ed. Diabetes: Its Medical and Cultural History. Berlin-Heidelberg: Springer Verlag; 1989:62–63.
Medvei VC. A History of Endocrinology. Boston, MA: MTP Press; 1982:11.
Brown-Séquard CE. Du role physiologique et therapeutic d’un suc extrait de testicules d’animaux, d’aprés nombre de faits observés chez l’homme. Arch Phisiol Norm Pathol. 1889;1:39–746.
Brown-Séquard CE, d'Arsonval A. De l’injection des extraits liquids provenant des glandes et des tissues de l’organism comme méthode thérapeutique. Comp Rend Soc Biol. 1891;3:248–250.
Kocher ET. Ueber Kropfexstirpation und ihre Folgen. Arch Klin Chir. 1883;29:254–337.
Murray GR. Note on the treatment of myxedema by hypodermic injections of an extract of the thyroid gland of a sheep. Br Med J. 1891;i:796–797.
Murray GR. The life-history of the first case of myxedema treated by thyroid extract. Br Med J. 1920;i:359–360.
Aminoff MJ. Brown-Séquard: An Improbable Genius Who Transformed Medicine. New York, NY: Oxford University Press; 2011.
Caparelli A. Zur Frage des experimentellen Pankreas-diabetes. Biol Zbl. 1893;13:495–498.
Borell M. Organotherapy, British Physiology, and discovery of the internal secretion. J Hist Biol. 1976;9:235–268.
Schäfer EA. Address in physiology on internal secretions. Lancet. 1895;2:321–324.
Laín-Entralgo P. Historia de la medicina moderna y contemporánea. Barcelona-Madrid: Científicomédica; 1963.
Henderson J. Ernest Starling and “hormones”: an historical commentary. J Endocrinol. 2005;184:5–10.
Obituary. The late Prof. Gley. Lancet. 1930:1030.
Medvei VC, Gley E. In: Medvei VC. A History of Clinical Endocrinology. Boston: MTP Press; 1982:737.
Nomination Database. Nobelprize. Org. Nobel Media AB 2014. Available at: https://www.nobelprize.org/nomination/redirector/?redir=archive/show_people.php&id=3484. Accessed January 16, 2019.
Gley E. Les Sécrétions internes: principes physiologiques, applications a la pathologie. Paris, France: B. Baillière; 1914.
Gley E. The theory of internal secretion: its history and development. Practitioner. 1915:2–15.
Gley E. The Internal Secretions. New York, NY: Paul B. Hoeber; 1917.
Gley É. Procédé de destruction du pancréas. Troubles consécutifs a cette destruction. C R Soc Biol. 1891;3:225–228.
Gley É. Note préliminaire sur quelques effets de la destruction lente du pancreas; importance de la function digestive du pancréas. C R Soc Biol. 1892;4:841–846.
Action des extraits de pancreas esclerosé sur des chiens diabétiques (par extirpation du pancréas). C R Soc Biol. 1922;2:1322.
Gley É. Sur la sécrétion interne du pancréas et son utilisation thérapeutique. C R Soc Biol. 1922;2:1322–1325.
Merton RK. Priorities in scientific discovery: a chapter in the Sociology of science. Am Sociol Rev. 1957;22:635–659.
Macleod JJR. Carbohydrate Metabolism and Insulin. New York, NY: Longmans, Green and Co. Ltd.; 1926:68.
Gley É. Letter to the Société de Biologie (Paris) dated February 20, 1905. C R Soc Biol. 1922;87:1322–1323.
Rennie J, Fraser T. The islets of Langerhans in relation to diabetes. Biochem J. 1907;21:7–19.
Zuelzer GL. Ueber Alimentäre Glycosurie in Krankeiten and Ueber Puerperale Lactosurie. Berlin, Germany: Med. Diss.; 1893.
Zuelzer GL. Experimentalle Untersuchungen über den Diabetes. Berl Klin Wschr. 1907;44:474–475.
Zuelzer GL. Ueber Versuche einer specifischen Fermenttherapie des Diabetes. Zeitschrift für experimentell pathologie und therapie. 1908;5:307–318.
Zuelzer GL, Dohrn M, Marxer A. Neure Untersuchungen über den experimentellen Diabetes. Dtsch Med Wschr. 1908;32:1380–1385.
Mellinghoff KH. Georg Ludwig Zuelzers Beitrags zur Insulinforschung. Düsseldorf, Germany: Med. Diss.; 1971.
Forschbach J. Versuche zur Behanlung des Diabetes mellitus mit dem Zuelzerschen Pankreas-hormon. Dtsch Med Wschr. 1909;35:2053–2055.
Reuter C. La secretion interne du pancréas et le traitement du diabète sucre. Section des Sciences naturelles, physiques et mathématiques (Nouv. Série). 1924;8:87–100.
Pierret E. La fonction endocrine du pancréas et la décuverte de l’insuline—Rapport sur le conférence de M. Camille Reuter. Soleuvre/(Differlange). Bulletin de la Societé des naturalists luxembourgeois. 1924;34:7–15.
Zuelzer WW. Reflections of a former pediatrician, accepting the Howland Award. Pediatr Res. 1985;19:1369–1372.
Banting FG, Campbell WR, Fletcher AA. Further clinical experience with insulin (pancreatic extracts) in the treatment of diabetes mellitus. Br Med J. 1923;1:8–12.
Best CH, Scott DA. The preparation of insulin. J Biol Chem. 1923;57:709–723.
Lindsten J. August Krogh and the Nobel Prize to Banting and Macleod. 2001. Available at: https://www.nobelprize.org/prizes/uncategorized/august-krogh-and-the-nobel-prize-to-banting-and-macleod/. Accessed January 16, 2019.
Zuelzer GL. Über Acomatol, das deutsche Insulin. Med Klin. 1923;47:1551–1552.
Zuelzer GL. The overcoming of diabetes. New facts about “Insulin”. (Unpublished article). October 16, 1923, copy in Banting Papers, Box 62, Folder 26. University of Toronto Archives. Digital ID: W10041. MS COLL. 76 (Banting) Box 62, Folder 26. Available at: https://insulin.library.utoronto.ca/islandora/object/insulin%3AW10041. Accessed January 16, 2019.
Macleod JJR. A lecture on insulin. Br Med J. 1923:165.
Macleod JJR. The physiology of insulin and its source in the animal body: nobel lecture, May 26, 1925. In: Nobel Lectures, Physiology or Medicine 1922-1941. Amsterdam: Elsevier; 1965:71–81.
Macleod JJR. Carbohydrate Metabolism and Insulin. New York, NY: Longmans, Green and Co. Ltd.; 1926;56:66.
Zuelzer G. Typescript letter signed by G. Zuelzer to Professor Macleod, 7/10/1927. Insulin Collection. U of T Libraries. Digital Image. MS. COLL. 241 (Best) Box 52, Folder 30. Available at: https://insulin.library.utoronto.ca/islandora/object/insulin%3AL10051. Accessed January 16, 2019.
Macleod JJR. Carbon copy of a typescript letter signed by JJJR Macleod to Professor G. Zuelzer. Insulin Collection. U of T Libraries. Digital Image. MS. COLL. 241 (Best) Box 52, Folder 30. Available at: https://insulin.library.utoronto.ca/islandora/object/insulin%3AL10200. Accessed January 16, 2019.
Zuelzer G. Typescript letter signed by G. Zuelzer to Professor Macleod, 5/11/1927. Insulin Collection. U of T Libraries. Digital Image. MS. COLL. 241 (Best) Box 52, Folder 30. Available at: https://insulin.library.utoronto.ca/islandora/object/insulin%3AL10201. Accessed January 16, 2019.
Murray I. The search for insulin. Scottish Med J. 1969;14:286–295.
Zeidman LA. Neuroscience in Nazi Europe Part III: Victims of the Third Reich. Can J Neurol Sci. 2012;39:729–746.
Schagen U. GeDenkOrt.Charité: People. Berlin, Germany: Charité - Universitätsmedizin Berlin. 2013. Available at: https://gedenkort.charite.de/projects/people/. Accessed January 16, 2019.
Schagen U, Schleiermacher S. 1933–1945: Under the Swastika. In: Bleker J, Hess V, eds. The Charité, History of a Hospital. Berlin, Germany: 177–178.
Schleiermacher S. Wer wurde vertrieben? Wie wenig wissen wir? Die Vertreibungen aus der Berliner Medizinischen Fakultät 1933 – Überblick. In: Schagen U, Schleiermacher S, eds. In: Die Charité im Dritten Reich. Die Indienstnahme medizinischer Wissenschaft im Nationalsozialismus. Pederborn: Schöningh Verlag; 2008:51–66.
Müller T. Die Neurologische Abteilung des Krakenhauses Lankwitz. Ein Beitrag zur Geschichte des Wissenschaftstransfers, der Emigration un des Berliner Krakenhauses. Sudhoffs Arch. 2004;88:54–76.